Relmada Therapeutics, Inc. (RLMD) stock
RLMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.61−0.60 (-14.25%)
Close on Nov 16, 2026Market cap $385.08MP/E –Yield –
Relmada Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
No profit margin figures for Relmada Therapeutics
Relmada Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?